close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Health & Science Health care industry Companies
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags U/S/ Markets Hims & Hers Health Inc Markets
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Sanofi SA US: News Business
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags NVIDIA Corp Interest Rates Paramount Global
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Novo Nordisk A/S Dow Jones Industrial Average NVIDIA Corp
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags U/S/ Markets Prescription drugs Mondelez International Inc
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Health care industry Health & Science Companies
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Viking Therapeutics Inc CVS Health Corp Gilead Sciences Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Health & Science Health care industry Oracle Corp
From CNBC.com News
5 things to know before the stock market opens
Tags Nasdaq Inc Walt Disney Co Markets
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Eli Lilly and Co Asia: Top News and Analysis Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Biotech and Pharmaceuticals Biotechnology Eli Lilly and Co
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe Markets Pharmaceuticals Europe News
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health & Science Labor economy Health care industry
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Biotechnology Biotech and Pharmaceuticals Alphabet Inc
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Prices Ibex Ltd Europe Markets
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee benefits Social issues Health insurance
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Health care industry Health & Science Business News
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Markets U/S/ Markets Datadog Inc
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Exchange/traded funds Pharmaceuticals Breaking News: Investing
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Technology Goldman Sachs Group Inc Breaking News: Technology
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Business News Novo Nordisk A/S Business
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Health & Science Health care industry Breaking News: Technology
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Health & Science Health care industry Roche Holding AG
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Health & Science Health care industry Social issues
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Business News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Eli Lilly and Co Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Health & Science Structure Therapeutics Inc Health care industry
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Health care industry Health & Science Business News
From CNBC.com News
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.